Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 3:14 PM ET


Company Overview of CollaGenex Pharmaceuticals, Inc.

Company Overview

CollaGenex Pharmaceuticals, Inc. develops and markets proprietary medical therapies to the dermatology market. Its lead development candidates include COL-118, a topical compound for the treatment of erythema (skin redness) associated with dermatological conditions; becocalcidiol, a vitamin D analogue, which is in a Phase II dose-finding clinical trial for the topical treatment of psoriasis; and Restoraderm, a proprietary foam-based, topical dermal drug delivery system. The company offers Oracea for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients; Alcortin, a prescription topical antifungal steroid combination; and Novacort, a prescription topical st...

41 University Drive

Newtown, PA 18940

United States

Founded in 1992

147 Employees





Key Executives for CollaGenex Pharmaceuticals, Inc.

Vice President, Treasurer and Director
Vice President, Secretary and Director
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
X-Cell Medical, Inc. United States
Acer Therapeutics Inc. United States
Symphony Allegro, Inc. United States
Nurix, Inc. United States
Sanofi-Topaz Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CollaGenex Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at